FORWARD FEATURES CALENDAR

Funds

Bregal Partners invests in OmniForce

Private investment firm Bregal Partners has made an investment in OmniForce in partnership with OmniForce’s management team and founder.   Los Angeles-based OmniForce is an athletic event production company. Its services include participant marketing and event publicity, participant training and fundraising support, sponsorship sales, and event planning and logistics.   In

Estancia makes minority investment in SGA

Private equity fund Estancia Capital Partners has acquired a minority non-controlling interest in Stamford, Connecticut-based Sustainable Growth Advisers (SGA).   SGA is a boutique traditional equity manager focused on providing high value-added active US and global growth equity mandates for sophisticated clients. Terms of the transaction were not disclosed.  

Biotechnology

Chiesi Group to acquire Zymenex

Chiesi Group, a European pharmaceutical company, has signed through its UK affiliate Chiesi Ltd a definitive agreement with Sunstone Capital to acquire Zymenex, a biopharmaceutical group focused on research and development of biologic therapeutics for the treatment of rare and life threatening genetic diseases.   Terms of the transaction have

Jeff Greenberg, chief executive of Aquiline

Aquiline Capital Partners invests in Tourmalet Advisors

Aquiline Capital Partners has made an investment, through affiliates, in Tourmalet Advisors, an alternative investment manager based in Fairfield, Connecticut.   Tourmalet, led by chief executive officer Michael Corasaniti, was founded in October 2009 and has a track record of managing, investing, structuring and trading distressed residential mortgage assets. The

Keating Capital makes additional USD1m investment in SilkRoad

Keating Capital, a pre-IPO investor and business development company, has made an additional USD1m convertible note investment in SilkRoad, an existing portfolio company.   Keating Capital’s investment is part of a USD16m growth financing round completed by SilkRoad.   Other participants in the financing include Foundation Capital, Intel Capital, Azure

Clouds

Thoma Bravo completes take-private acquisition of Keynote

Private equity firm Thoma Bravo has completed its acquisition of Keynote Systems, a provider of internet and mobile cloud testing and monitoring, for USD20 per share or approximately USD395m. With the transaction completed, Keynote’s stock will cease trading on the Nasdaq under the ticker symbol KEYN.   Keynote will remain

Marketing

TagMan receives USD5m in funding

TagMan, a tag management system, marketing data and marketing attribution provider, has received USD5m in new funding. Existing investors Greycroft Partners and iNovia Capital led the financing, and Silicon Valley Bank also injected capital.   TagMan plans to use the awarded funds to ramp up growth of its 300-strong global

Drugs 2

MicuRx completes USD25m series B financing

MicuRx Pharmaceuticals, a privately-held biopharmaceutical company developing next-generation antibiotics, has raised USD25m in series B financing. Led by BVCF, a private equity and growth fund specialising in the life sciences industry, the round also includes existing investors Morningside Group and Devon Park Bioventures.   Proceeds from the series B financing

Events

12 November, 2026 – 5:00 pm

Directory Listings